
CanSino Biologics Inc
SSE:688185

Intrinsic Value
The intrinsic value of one
CanSino Biologics Inc
stock under the Base Case scenario is
64.29
CNY.
Compared to the current market price of 58.61 CNY,
CanSino Biologics Inc
is
Undervalued by 9%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
CanSino Biologics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
CanSino Biologics Inc
Balance Sheet Decomposition
CanSino Biologics Inc
Current Assets | 4.4B |
Cash & Short-Term Investments | 3.3B |
Receivables | 687.3m |
Other Current Assets | 398.8m |
Non-Current Assets | 3.6B |
Long-Term Investments | 166m |
PP&E | 2.5B |
Intangibles | 264.7m |
Other Non-Current Assets | 698.9m |
Free Cash Flow Analysis
CanSino Biologics Inc
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
CanSino Biologics Inc
Revenue
|
748.5m
CNY
|
Cost of Revenue
|
-241.7m
CNY
|
Gross Profit
|
506.8m
CNY
|
Operating Expenses
|
-1.2B
CNY
|
Operating Income
|
-667.8m
CNY
|
Other Expenses
|
-52.4m
CNY
|
Net Income
|
-720.1m
CNY
|
Profitability Score
Profitability Due Diligence
CanSino Biologics Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Score
CanSino Biologics Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
CanSino Biologics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Score
CanSino Biologics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
CanSino Biologics Inc
According to Wall Street analysts, the average 1-year price target for
CanSino Biologics Inc
is 67.67 CNY
with a low forecast of 54.54 CNY and a high forecast of 82.61 CNY.
Dividends
Current shareholder yield for CanSino Biologics Inc is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CanSino Biologics Inc
stock under the Base Case scenario is
64.29
CNY.
Compared to the current market price of 58.61 CNY,
CanSino Biologics Inc
is
Undervalued by 9%.